To find CRC samples harboring an oncogenic mutation of K‐Ras gene, we employed an assay system to screen for point mutations of the K‐Ras gene at codon 12 and 13 using quantitative PCR, as reported previously (van Eijk et al., 2011). The gene discussed is KRAS; the disease is colorectal carcinoma.